Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - CorMedix Inc. | Financial_Report.xls |
| 10-Q - FORM 10-Q - CorMedix Inc. | v239557_10q.htm |
| EX-31.2 - EXHIBIT 31.2 - CorMedix Inc. | v239557_ex31-2.htm |
| EX-32.2 - EXHIBIT 32.2 - CorMedix Inc. | v239557_ex32-2.htm |
| EX-32.1 - EXHIBIT 32.1 - CorMedix Inc. | v239557_ex32-1.htm |
| EX-10.2 - EXHIBIT 10.2 - CorMedix Inc. | v239557_ex10-2.htm |
| EX-31.1 - EXHIBIT 31.1 - CorMedix Inc. | v239557_ex31-1.htm |
| EX-10.5 - EXHIBIT 10.5 - CorMedix Inc. | v239557_ex10-5.htm |
| EX-10.1 - EXHIBIT 10.1 - CorMedix Inc. | v239557_ex10-1.htm |
| EX-10.4 - EXHIBIT 10.4 - CorMedix Inc. | v239557_ex10-4.htm |
Exhibit 5.1 A
Clinical Development Timeline for Shiva 102
The following clinical development timeline provides a detailed timeline for the next *** and general outline for subsequent development. Details of the Development Plan are contained in the CorMedix Global Development Plan for Deferiprone dated as of the effective date of Amendment 3 and attached hereto as Exhibit 5.1 B.
|
2011
|
|
|
***
|
|
|
***
|
|
|
***
|
|
|
***
|
|
|
***
|
|
|
***
|
|
|
***
|
|
|
***
|
|
|
***
|
|
|
***
|
|
|
***
|
|
|
***
|
|
|
***
|
|
|
***
|
|
|
***
|
|
|
***
|
|
|
***
|
|
|
***
|
|
|
***
|
|
|
***
|
|
|
***
|
|
Exhibit 5.1 A
Clinical Development Timeline for Shiva 102
The following clinical development timeline provides a detailed timeline for the next *** and general outline for subsequent development. Details of the Development Plan are contained in the CorMedix Global Development Plan for Deferiprone dated as of the effective date of Amendment 3 and attached hereto as Exhibit 5.1 B.
|
2012
|
||
|
***
|
||
|
***
|
||
|
***
|
||
|
***
|
||
|
***
|
||
|
***
|
||
|
***
|
||
|
***
|
||
|
***
|
||
|
***
|
||
|
***
|
||
|
***
|
||
|
***
|
||
|
***
|
||
|
***
|
||
|
***
|
||
|
***
|
||
|
***
|
||
|
***
|
||